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unstable symptoms preoperatively, Their medical records were reviewed for 
fatal and nonfatal adverse events, 
Results: Perioperatlve death occurred in 1 pt (3%) duo to cardiogenlc 
shook from acute myocardial Infarction (AMI), Perloperative morbidity in- 
eluded: 
Ca~lac Non-Cardiac 
Angina 10 (32%) Ronnl Failure 2 (Q%) 
AMI 2 (0%) CVA 1 (3%) 
CHF S (26%) 8epalel 1 (3%) 
Arrhythmla 4 (13%) Trsnaf,alon 6 (19%) 
Concluslorm: Psrloperstlva morlallty and noncardlec morbidity In pts with 
class III or IV angina pectorls undergoing Isolated TMR ts tow, Compared to 
conventional coronary artery bypass surgery, TMR pts are at higher risk for 
pedoperatlve cardiac event~, likely reflecting the lack of Immediate benefit 
from the procedure In the setting of severe CAD, These pie merit vlgllnnt 
surveillance for adverse cardiac events Dad aggressive medical management 
In the perioperetlve period, 
~ Clinical Experience With l 'renamyo©ardlal 
Rsvaseularlzatlon Util izing a Holmlum;¥AG Laser 
K,B, Allan, R,D, Dowltng, D,A, Helmansohn, E, Raltsma, L,T, Dldelot, 
C,J, She, at, St, Vincent Ho.~ltal, Indianapolis, Indlan~; Unlve~tty of 
Louisville, Louisville, Kenfuc~, U,~4 
~¢'/~ground: In the Unltod States. studies hove boon undo~ay since 1995 to 
assess the safety and efficacy o1 Tmnsmyocardtal ravascularlzatlon (TMR) 
u~lng e. holmlum:YAG later, 
Methods: TMR was pedormod in 42 patients with rafrsgtory angina who 
were not candidates for PTCA or CABG (mean age 62 • 11, range 38-79 
yeare), Patients had either Class IV angina (n = 23) or had unstable angina 
(n = lg) and were unwoanable from Intravenous nitroglycerin, Preoperative 
thallium studies Identified the extent and location of rever~lbte Ischomla, 
Operative exposure was via a Ilmltsd left anterior thoracotomy, An average 
of 45 ,-.t: 11 laser channels ware created with a mean operative time of 106 
38 minutes, 
Results: At three months follow.up (n = 23) mean angina class was 1.5 
:i: 0,1 (p < 0,001), nnd at six months follow-up (n = 11) moan angina class 
was 1,1 ± 0,1 (p < 0.002); versus 4,0 ± 0 at baseline. Mortality was 12% 
(5/42) with no late deaths, Complications Included ventdcular arrhythmlas 
12% (5/42), Intraeortlc balloon placement 12% (5/42), reoperatlon for chest 
wall hemorrhage 2% (1142), and respiratory failure requiring relntubatlon 2% 
(1142), Median postoperative length of stay was 5,5 ± 4.9 (range 1-25) days. 
Conclusion: Transmyooardtal ravascularizatlon with a Ho:YAG laser re, 
suits in a significant reduction in angina class and is beneficial in patients 
with refractory angina untroatable by conventional methods, 
~-'112~ Long-Term Outcome o l  Congen i ta l  Hear t  
D isease :  Adu l t  Wi th  Congen i ta l  Hear t  
D isease  
Tuesday,  March 31, 1998, Noon-2 :00  p.m. 
Georg ia  Wor ld  Congress  Center,  West  Exhibit Haft Level  
Presentat ion Hour: Noon-1 :00  p.m. 
I 1"120"1S4'1 Outcome In Patients With Clinically Silent 
Coronary Artery Fistulae 
M.C, Sherwood, S. Rockenmachor, S,D. Colan. T, Geva, Children's 
Hospital, Boston, Massachusetts, Lahey Hitchcock Clinic, Manchester, New 
Hampshire, USA 
Background: With the advent of high resolution 2-D and color echo the de- 
tection rate of clinically silent coronary artery fistulae (CAF) has increased. 
Because the clinical significance and outcome of these CAF has not been de- 
tined, this study aims to determine the clinical significance of echo diagnosed, 
clinically silent CAE 
Methods: The echo, clinical, ECG. and angiogr'aphic findings and docu- 
mented follow-up of 31 patients, mean age 7.2 ~ 8,4 years (range 0.01.-39.9) 
at presentation, with an unsuspected echo finding of CAF (1986.-1997), were 
analyzed. Smusoids and small fistulae following tntracardiac surgery were 
excluded. 
Results: The indications for echo were known heart disease (n = 2), 
murmur (n = 23), cardiomegaly (n = 2). chest pain (n = 1), strider (n = 1), 
syncope (n = 1) and chest trauma (n = 1). Cardiac anomalies (n = 10) were 
ASD, VSD, bicuspid aortic valve, mild Ebstein's anomaly, coamtation LV 
aneurysm, and RA appendage hemangioma. CAF were detected with color 
Doppler In all patients. The origin was from the left coronary system (n = 27). 
dght coronary system (n = 3) and bllatsral (n = 1). The entry sites were the PA 
(n = 18), RV (n = 8), RA (n = 2) and LV (n = 3). The entire length of CAF was 
visualized in 14 patients. Anglogrsphy (n = 5) confirmed the echo findings (n 
= 2). and delineated the origin (n = 2) or entry point of CAF (n = 1), Follow.up 
was to mean age 8,; ± 8.4 years (range 0.3.-42,0). Spontaneous closure 
of CAF (n ,  7) occurred st mean age 6.8 ± 4.3 years (range 0,3-13.7), 
In 23 patients CAF persisted, without Intervention. All patients remained 
asymptomattc, with no adverse clinical events or ECG evidence of Ischomle 
at mean ego at follow.up of 9,3 ± 9.1 yearn (range 0,3-42,0), 
Conclusion: Based on thls experience there was no evidence that din. 
tcslly silent CAF that am diagnosed Incidentally by echo ere aoaoclatsd 
with adver,~e clinical outcomes, Conservative management of theme patients 
appears to I~o appmprlnts, 
~ Out©omes of  Aort ic Valve Stenoals Present ing In 
Neonates 
S, Bnrsm, B,W, McCfledle, R,M, Freedom, D Nykanen, The HasP. torSick 
Children, Univ, Of Tomn~ Canada 
/]net(ground; Management Of isolated aedic valve stenosis (AVS) mquffing 
intervention at age ~.3 me is controversial, We sought 1o define factors 
associated with outcomes after neonatal presentation, 
Mefhod~: From 1185 to 12/96, 62 infants presented with AVS at ,-3 me of 
age; 7 wore excluded due to significant mltrat valve abeomlalitres (4 died). 
Clinical, echo, hamoclynamic and ang;ogrephic, management and outcome 
data were obtained, 
Results: Median ago at presentation was 6cl, with only murrour in 30, 
signs of CHF in 20 and poor peduslen/sheck in 5 pts, Initial echo showed 
reduced LV function in 26%. with a moan peak instantaneous gradient of 69 
± 30 mmHg in those with normal function, There were 4 deaths (/%). all 
with poor function and before age 1,4 me. with survival thereafter of 92% 
(g5%cI, 85-.99,6%) up to age 11,9 yrs. Initial intervention was transcatbater 
dilation In 23 and surgical valvotomy in 20 pie, with 12 baying no inten'ention 
to date, Freedom from intervention for AVS was 69% at age 1 wk, 58% at 1 
me, 35% at 3 me, 29% at 1 yr and 19% at ago 5 yr, Addihonat intewentmns 
were mquirsd in 14 pts, Patients without poor pedusiontshock, normal LV 
function and peak instantaneous gradients <60 mmHg at presentation (n = 
19. Group I) vs, pts with poor function or initial gradients >60 mmHg (n = 36. 
Group II) had better survival (I-0 vs, 11--4 deaths), and longer freedom from 
intervention at age 1 wk (I-100% vs. 11-53%), 1 me (I-95% vs. 11-39%). and 6 
me (I-79% vs. 11-12%) (p = 0,0001). 
Conclusions: The majoflty of neonates presenting with AVS require inter- 
vention, although this may be safely delayed =n selected patients with lower 
initial gradients and good LV function. 
J 1120-156 J Course of  Right Ventricular Funct ion in Patients 
With Pu lmonary  Insuff iciency After Repair  o f  
Tetralogy ot  Fatter 
M,S, Schambarger, R,A. Hurwitz. Indiana Universi~. Indianapohs. IN, USA 
Background: Surgical repair of Tetralogy of Fagot (ToF) frequently results in 
pulmonary insufficiency (PI). Nevertheless, little information is available on 
the Ion9 term impact of PI on right ventrleular function. 
Methods: 21 patients with at least moderato PI alter repair of ToF were 
studied serially by radionuclide angiocardiography. The first (baseline) study 
was obtained a mean of 1.2 years (range 0.1 to 6.4) after surgery. The last 
study was podormed a mean of 10.2 years (range 4.6 to 16.9) after surgery. 
Results: The mean RVEF at baseline was 0.52 ~: 0.1 (normal: 0.53 -+- 
0.06; n,s.s). At the time of the last study the mean RVEF had decreased 
significantly to 0.45 ± 0.1 (p < 0.01). 
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At the last study, 7 patients (33%) had a RVEF <0A2, which is >2 
SD below our laboratory normal. Using 0.05 as our reproducibility factor for 
change in RVEF, 2 patients showed improvement in RVEF. 7 patients showed 
no change and 12 patients (57%) showed a decrease in RVEF. 
